http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008114976-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079a5b3eecbeb0e5fcc2e9b817b28c97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9716ec9fe10546c3c166973f3f8202cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54acb2a5890c4a9b4b8a410c7c5019a1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2008-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb03cc5d7aabb2ac760803c0fffd5890 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5aa3da390ef81f00ba9572ae712615c |
| publicationDate | 2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2008114976-A1 |
| titleOfInvention | Spinorphin derivatives as potent and selective human p2x3 receptor antagonist |
| abstract | The present invention relates to a spinorphin derivative useful as a potent and selective human P2X<SUB>3</SUB> receptor antagonist. More particularly, the present invention provides a spinorphin derivative useful as a potent and selective human P2X<SUB>3</SUB>receptor antagonist selected from peptide AVVYPWT, peptide LAVYPWT, peptide LVAYPWT, peptide LVVAPWT and/ or cyclic peptide LWYPWT. Human P2X<SUB>3</SUB> receptor antagonist has been developed on the electrophysiological evaluation of spinorphin peptide derivatives, truncated peptide analogues, cyclic peptides and a retroinverso peptide at human P2X<SUB>3</SUB> receptors to determine the channel blocking activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010062159-A1 |
| priorityDate | 2007-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.